Immunogenicity of Umbilical Cord Tissue Derived Cells
In a recent study, however, intracardiac allogeneic porcine mesenchymal stem cells were shown to elicit an immune response despite their low immunogenic profile in vitro. 15 The lack of MHCII and co-stimulatory molecule expression on the surface of unactivated MSCs may account for reduced immunogenicity of MSC. However, upon exposure to inflammatory cytokines such as interferon-gamma (IFN-γ), MHCII and other co-stimulatory molecules can be upregulated. 8 Xenogeneic systems may not be optimal models to directly assess immunogenicity as cytokines, such as interferon-gamma that affect MHCII expression and thus initiation of an immune response, may be incompatible and ineffective across species. Clinical cellular repair strategies will likely involve injection of allogeneic cells into inflamed regions of damaged tissue, and repeated doses of cells may be necessary to achieve the desired benefit. The assessment of immunogenicity of stem cell sources when injected repeatedly or in an inflammatory environment will be necessary for development of clinical protocols for effective cellular therapy.
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For personal use at PENN STATE UNIVERSITY on February 23, 2013 . bloodjournal.hematologylibrary.org From A cell population isolated from the digested tissue of human umbilical cords is currently being evaluated for potential clinical application for repair in cases such as retinal disease and myocardial infarction. Pre-clinical functional studies using human umbilical cord tissue derived cells (UTC) are currently in progress, and early results show promise for these UTC as cellular therapy of retinal disease in animal models. 16 MGH MHC-defined miniature swine [17] [18] [19] provide a unique pre-clinical model to assess immunogenicity of allogeneic UTC. By approximating donor-recipient mismatch barriers often seen in clinical transplants, these animals have been utilized for large animal studies of cellular and solid organ transplantation. [20] [21] [22] We now report the isolation and characterization of a porcine analog of human UTC derived from miniature swine. We also describe the evaluation of immunogenicity of these cells utilizing intravenous and subcutaneous injections across full allogeneic MHC barriers.
Materials and Methods

UTC Isolation and Culture
Umbilical cords were isolated from four MGH MHC-defined miniature swine leukocyte antigen (SLA) dd fetuses delivered at term through cesarean section. Porcine UTC were extracted by the same procedure as described for isolation of human UTC. 16 Briefly, cords were drained of all blood, washed in phosphate-buffered saline and then mechanically dissociated and digested using a mixture of the enzymes collagenase (10 U/mL, Sigma, St. Louis, MO), dispase (12.6 U/mL, Roche Diagnostics, Indianapolis, IN), and hyaluronidase (1 U/mL, Vitrase®, ISTA Pharmaceuticals, Irvine, CA) diluted in DMEM-low glucose medium (Invitrogen, Carlsbad, CA). After digestion at 37˚ C for 2 hours, the processed tissue was centrifuged, washed and 
Flow Cytometry
Porcine UTC were analyzed by surface staining and flow cytometry to determine surface phenotype as previously described for human UTC. Fluorescence was visualized using the appropriate filter on an inverted epi-fluorescent microscope (Nikon, Lake Placid, NY). Representative images were captured using a digital color videocamera and ImagePro software (Media Cybernetics, Carlsbad, CA).
Activation of UTC by IFN-γ Stimulation
Porcine and human UTC were seeded after thaw at 5,000 per cm 2 in growth media and incubated at 37°C, 5% CO 2 . After 5 days, 80ng/ml swine IFN-γ (Biosource International, PSC4030) and 25ng/ml human IFN-γ (Pierce, RIFNG50) were added to porcine and human UTC cultures respectively. UTC were harvested with trypsin 48 hours later and washed with media prior to flow cytometric analysis of surface MHCI and MHCII expression.
Injection of Unactivated and Activated UTC
Cryopreserved porcine UTC were thawed, cultured for 4-5 days, harvested, resuspended in Lactated Ringer's solution at a concentration of 1x10 7 cells/ml and infused into fully allogeneic SLA cc or SLA ac recipient pigs at a total dose of 1x10 8 cells. For IV injections (n=2), unactivated pUTC were slowly infused at a concentration of 1 x 10 7 cells/ml in a total volume of 10cc through the IV catheter. For SC injections, a total of 4 skin injection sites were injected 7 only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From subcutaneously with 2.5cc of the cell suspension using a 25 gauge needle. For animals receiving repeated SC injections, a total of three doses of cells were administered separated at one month intervals. The first two doses were injected into the same site, while the third dose was injected at a disparate site.
Injection of UTC Near an Inflammatory Lesion
An inflammatory lesion was created in two animals using Complete Freund's Adjuvant (CFA) injected SC 1 week prior to pUTC injection. CFA (Pierce, 77140) at a volume of 2cc was injected SC using a 25 gauge needle. The pUTC were injected subcutaneously at 4 sites placed around the periphery of the CFA lesion using a 25 gauge needle.
Antibody Detection by Flow Cytometry
Antibody response to UTC was assayed by flow cytometry using sera collected at serial time points from injected animals to stain peripheral blood mononuclear cells (PBMC) that were haplotype matched to UTC (SLA dd ). Briefly, 10 µl of serum from each recipient was added to 
Mixed Lymphocyte Reaction (MLR)
Responder PBMC were plated in triplicate in 96-well flat-bottom plates (Costar, Cambridge, MA, USA) at a final concentration of 4 × 10 5 cells/well and were stimulated by an equal number of irradiated (25 Gy) stimulator PBMC. The medium consisted of RPMI 1640 supplemented with 6% fetal pig serum (FPS), 10 mM HEPES, 1 mM glutamine, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 100 U/mL penicillin, 100 µg/mL streptomycin, 50 µg/mL gentamicin, and 2x10 5 M 2-mercaptoethanol. Cultures were incubated for 2 and 5 days at 37˚C in 6% CO2 and 100% humidity. 3 H-thymidine was added for the last 6 hours of culture and wells were harvested onto Mash II glass fiber filters and counted for beta emission.
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For CFSE MLR, porcine PBMC responders were labeled using 5 uM carboxyfluorescein diacetate, succinimidyl ester (CFSE) in dimethylsulfoxide and the reaction was quenched with fetal bovine serum prior to MLR set up. Wells were harvested at days 3 and 5 of incubation to assess proliferation based on CFSE intensity by flow cytometry. With each successive generation in a population, proliferation is marked by a decrease in cellular fluorescence intensity that is readily followed by flow cytometry.
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Skin Grafting
A pUTC haplotype-matched SLA dd skin graft was placed at least 30 days following pUTC injection to confirm whether the animal was sensitized by the pUTC injection. Split thickness skin grafts were obtained from both a donor animal and the experimental animal using a dermatome. Skin was then placed on a graft bed, also prepared with the dermatome on the dorsum of the recipient animal. SLA dd and self skin grafts were monitored daily to determine acceptance or rejection of the skin based on three characteristics: texture, color, and temperature.
The Wilcoxon rank-sum test was used to assess for an association between antibody response prior to skin graft and the time to skin graft rejection. The exact two-sided p-value was computed by StatXact (Cytel, Cambridge, MA).
Results
Comparison of Porcine and Human Umbilical Cord Structure and Phenotype
Miniature swine umbilical cords were found to have a similar anatomy and structure as human umbilical cords with two exceptions: (1) the observance of an allantoic duct in pigs, and (2) increased vasculature within the connective tissue of the porcine cord as previously described. 28 The lack of an allantoic duct in the cross section of term human cord was not surprising as it is 10 only.
For Of the eight animals with detectable SLA dd antibody, five had titers up to 1:640 dilution, while the remaining three had higher titers >1:640 (Table 1) Rejection by all criteria was complete by post-graft day 6. In the animals injected with unactivated UTC around a CFA inflammatory lesion, self grafts were accepted while SLA dd skin grafts began to show evidence of rejection by day 2-4 post-graft, with complete rejection by day 6. For these animals, the patterns of skin graft rejection were consistent with a second-set rejection confirming prior sensitization from UTC injection. Antibody response prior to skin graft was associated with earlier skin graft rejection according to both the start of clinical signs and the completion of rejection (p=0.036). In all cases, the rejection of SLA dd skin grafts confirmed normal immunocompetence in UTC recipients with no evidence for tolerance induction.
In Vitro Responses to SLA dd PBMC Stimulation
In vitro responses to SLA dd stimuli were evaluated using MLR assays, either by a 3 H-thymidine pulsed or CFSE based method. Assays were harvested at an early incubation time point at day 2 for 3 H-thymidine assays or at day 3 for CFSE assays to distinguish sensitized from normal allo-
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For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From immune responses. Proliferation at these early harvests may be indicative of sensitization. 30 All assays were also harvested at day 5, the conventional time point for assessing the presence of alloresponses. All of these results are summarized in Table 1 . A detectable response at the early harvest was defined by fulfillment of one of the following criteria: 1) stimulation index (SI) >10;
2) ratio early harvest SI to day 5 SI >1; or 3) ratio of early harvest SI >2.5 when compared to that of the pre-treatment assay (applicable only to post-injection assays). From these early harvests, a detectable sensitized response was seen post-injection in both animals injected with activated, MHCII + UTC, in both animals receiving repeated injections of UTC after the second injection, and in only one of the two control animals injected with SLA dd PBMC. No other animals had a detectable early proliferative response by these same methods prior to rejection of a SLA dd skin graft. Following rejection of SLA dd skin, however, strong proliferative responses at days 2 or 3 MLR harvests could be detected. Taken together, these data suggest that early MLR harvest can detect strong sensitization responses but may not detect mild sensitization, which may occur with cellular injections. Detection of allo-antibody responses may be a more reliable indicator of sensitization following cellular injection. All animals evaluated had normal proliferative responses to SLA dd PBMC when harvested after five days of in vitro incubation.
Discussion
Human UTC have been reported as having potential for cellular repair. 16 Here we report the isolation and characterization of a porcine analog of human UTC and assess immunogenicity of this unique cell source using clinically relevant MGH MHC-inbred miniature swine.
Characterization of isolated porcine UTC confirmed that these cells are phenotypically similar to human UTC and could be used as an analog for human cells. Immunogenicity studies revealed 14 only.
For Overall, these findings suggest that care must be taken in the clinic to avoid sensitization against the cell therapy product. The environment into which UTC are injected is an important clinical consideration, especially if these cells are utilized for repairing damaged, inflamed tissues.
Repeated administration into the same location may cause rejection of previously engrafted cells and may negate the previously acquired benefits of therapy. Although we only investigated IFN-γ, it is also possible that other cytokines present in damaged tissues might affect expression of co-stimulatory molecules in addition to MHC on UTC, thereby increasing immunogenicity.
Clinical treatments using UTC may require careful timing to ensure inflammation at the planned Porcine UTCs were phenotyped using available porcine specific and known cross-reactive reagents by immunohistochemistry (a) and by flow cytometry ((b), UTC-filled curve; isotype negative control -hollow curve).
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